Please assess the completion status of the following clinical trial:

Trial Title: Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy postmenopausal woman~* Body mass index less than 30~* Practices normal eating habits~* Stops hormone replacement therapy at least 6 months prior to study entry~Exclusion Criteria:~* Currently taking hormone replacement therapy~* History of cardiovascular disease~* Family history of coronary artery disease~* Recent history of smoking, high blood pressure, or hyperlipidemia

- Gender: FEMALE
- Minimum Age: 55 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- estrogen plus progesterone (Type: EXPERIMENTAL): Hormone replacement therapy (HRT): estrogen plus progesterone
- estrogen plus placebo (Type: ACTIVE_COMPARATOR): Hormone replacement therapy (HRT): estrogen plus placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).